QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial

Cyclo Therapeutics (CYTH) News Today

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free CYTH Stock Alerts
$1.16
-0.04 (-3.33%)
(As of 04:00 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
MarketBeat logoComparing Cyclo Therapeutics (NASDAQ:CYTH) & Opthea (NASDAQ:OPT)
americanbankingnews.com - April 13 at 1:30 AM
finance.yahoo.com logoPleasing Signs As A Number Of Insiders Buy Cyclo Therapeutics Stock
finance.yahoo.com - April 10 at 9:44 AM
investorplace.com logoCYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023
investorplace.com - March 19 at 7:06 AM
businesswire.com logoCyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
businesswire.com - March 18 at 9:05 AM
finance.yahoo.com logoCyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease
finance.yahoo.com - March 14 at 3:03 PM
businesswire.com logoCyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer's Disease
businesswire.com - March 14 at 9:34 AM
finance.yahoo.com logoCyclo Therapeutics, Inc. (CYTH)
finance.yahoo.com - February 2 at 9:30 AM
markets.businessinsider.com logoCyclo Therapeutics Gets Notice Of Allowance For Patent Regarding Treatment Of Alzheimer's Disease
markets.businessinsider.com - January 29 at 12:14 PM
finance.yahoo.com logoCyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
finance.yahoo.com - January 29 at 12:14 PM
morningstar.com logoCyclo Therapeutics Inc CYTH
morningstar.com - January 3 at 10:30 PM
msn.com logoCytosorbents, Cyclo Therapeutics among healthcare movers
msn.com - December 28 at 2:48 PM
finance.yahoo.com logoCyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1
finance.yahoo.com - December 18 at 4:09 PM
finance.yahoo.com logoRafael Holdings Reports First Quarter Fiscal 2024 Financial Results
finance.yahoo.com - December 14 at 6:19 PM
businesswire.com logoAPPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied ...
businesswire.com - November 29 at 3:13 PM
finance.yahoo.com logoCyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024
finance.yahoo.com - November 21 at 10:04 AM
msn.com logoCyclo Therapeutics reports Q3 results
msn.com - November 15 at 1:19 PM
finance.yahoo.com logoCyclo Therapeutics Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 15 at 8:19 AM
seekingalpha.com logoWISH, REAL and PIXY among mid-day movers
seekingalpha.com - November 10 at 8:24 PM
finance.yahoo.com logoSeveral Insiders Invested In Cyclo Therapeutics Flagging Positive News
finance.yahoo.com - November 2 at 10:15 AM
finance.yahoo.com logoRafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
finance.yahoo.com - October 30 at 6:00 PM
finance.yahoo.com logoCyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million
finance.yahoo.com - October 23 at 1:02 PM
finance.yahoo.com logoCyclo Therapeutics to Present at 8th Annual Dawson James Conference
finance.yahoo.com - October 5 at 12:45 PM
tmcnet.com logoCYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to Shareholders
tmcnet.com - September 21 at 1:08 PM
finance.yahoo.com logoCyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
finance.yahoo.com - September 21 at 8:07 AM
finance.yahoo.com logoCyclo Therapeutics Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 15 at 6:55 PM
benzinga.com logoCyclo Therapeutics And This Other Penny Stock Insiders Are Buying
benzinga.com - August 3 at 12:24 PM
benzinga.com logoCyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol® Cyclo™ for Alzheimer's Disease
benzinga.com - June 12 at 6:48 PM
finance.yahoo.com logoPositive Signs As Multiple Insiders Buy Cyclo Therapeutics Stock
finance.yahoo.com - May 22 at 10:43 AM
finance.yahoo.com logoCyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 15 at 8:24 AM
finance.yahoo.com logoCyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)
finance.yahoo.com - May 2 at 8:58 AM
benzinga.com logoCyclo Therapeutics Stock (NASDAQ:CYTH), Guidance and Forecast
benzinga.com - April 28 at 2:04 AM
finance.yahoo.com logoCyclo Therapeutics Announces Closing of $1.3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
finance.yahoo.com - April 21 at 12:17 PM
msn.com logoCyclo Therapeutics's Return On Capital Employed Insights
msn.com - March 21 at 2:33 PM
marketwatch.com logoCyclo Therapeutics in Talks About Possible Combination
marketwatch.com - March 20 at 7:03 PM
finance.yahoo.com logoCyclo Therapeutics Provides Business Update and Reports Full Year 2022 Financial Results
finance.yahoo.com - March 20 at 8:58 AM
seekingalpha.com logoCYTH Cyclo Therapeutics, Inc.
seekingalpha.com - March 15 at 11:22 PM
benzinga.com logoCyclo Therapeutics Chief Operating Officer Awarded $44K Worth of Stock Options
benzinga.com - March 10 at 5:24 PM
benzinga.com logoCyclo Therapeutics Chief Regulatory Officer Awarded $44K Worth of Stock Options
benzinga.com - March 10 at 12:23 PM
benzinga.com logoCyclo Therapeutics Board Member Awarded $3K Worth of Stock Options
benzinga.com - March 10 at 12:23 PM
barrons.com logoCyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol(R) Cyclo(TM) for the Treatment of Early Alzheimer's Disease
barrons.com - January 11 at 11:03 PM
finance.yahoo.com logoCyclo Therapeutics Provides Clinical Program Update and Highlights Recent Achievements
finance.yahoo.com - January 11 at 1:03 PM
finance.yahoo.com logoCyclo Therapeutics to Present at the Virtual Investor 2023 Companies to Watch Event
finance.yahoo.com - January 10 at 10:11 AM
benzinga.com logoCyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer's Disease
benzinga.com - January 9 at 1:16 PM
finance.yahoo.com logoCyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease
finance.yahoo.com - January 9 at 8:15 AM
finance.yahoo.com logoCyclo Therapeutics Announces Closing of $4.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
finance.yahoo.com - January 4 at 4:19 PM
finance.yahoo.com logoCyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
finance.yahoo.com - January 4 at 11:18 AM
msn.com logoCyclo Therapeutics announces direct offering for up to $4.2M
msn.com - December 30 at 10:05 AM
finance.yahoo.com logoCyclo Therapeutics Announces $4.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
finance.yahoo.com - December 30 at 10:05 AM
msn.com logoWhy Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session
msn.com - December 2 at 7:28 PM
finance.yahoo.com logoCyclo Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Achievements
finance.yahoo.com - November 11 at 10:18 AM
Get Cyclo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter.

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

CYTH Media Mentions By Week

CYTH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYTH
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

CYTH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYTH Articles
This Week
▼
1

0
▲
CYTH Articles
Average Week

Get Cyclo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:CYTH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media